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Summary. Thrombospondin-l (TSP-1) is a matrix 
protein implicated in mechanisms of wound healing. 
TSP-1 contains the sequence cysteine-serine-valine- 
threonine-cysteine-glycine (CSVTCG) that has been 
shown to function primarily as a cell adhesion domain. 
Our laboratory has isolated a novel receptor specific for 
the CSVTCG adhesive domain of TSP-1. Immunohisto- 
chemical staining techniques and computerized image 
analysis were used to identify and quantitate TSP-1 and 
its CSVTCG receptor in surgically created colon 
anastomotic wounds. Histopathologic and quantitative 
examination demonstrated increased expression of TSP- 
1 and its CSVTCG receptor in areas of wound healing. 
These findings suggest a role for  TSP-1 and its 
CSVTCG receptor in wound healing. The control of 
expression and activity of these molecules may 
eventually be the basis for the development of wound 
healing agents that could significantly reduce the 
morbidity from surgical intervention. 
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Introduction 
Thrombospondin-l  (TSP- l ) ,  a 450 kilodalton 
glycoprotein released by platelets in response to 
physiological activators (such as thrombin and collagen), 
was first discorvered in 1971 (Lahav, 1993; Lawler and 
Hynes, 1986). A variety of cells synthesize and secrete 
TSP-l including fibroblasts (Jaffe et al., 1983), smooth 
muscle cells (Raugi et al., 1982), and endothelial cells 
(McPherson et al., 1981). The structure of TSP-1 is 
conserved among various animal species as shown by 
amino acid sequence homology and antibody 
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crossreactivity (Switalska et al., 1985; Lahav, 1993). 
Like fibronectin, TSP-1  is composed of linear 
polypeptide domains that specifically interact with 
a number of macromolecules, including heparin 
(Yabkowitz et al., 1989), fibrinogen (Tuszynski et al., 
1985), collagen (Mumby et al., 1984), and plasminogen 
(DePoli et al., 1989). 
TSP-1 plays a major role in cell adhesion and cell- 
cell interaction. TSP-1 has been shown to promote the 
cell-substratum adhesion of a variety of cells, including 
platelets, melanoma cells,  smooth muscle cells,  
endothelial cells, fibroblasts, and epithelia1 cells 
(Tuszynski et al., 1987).  Cells with specialized 
functions, such as keratinocytes (Varani et al., 1988) and 
osteoblasts (Robey et al., 1989), attach to TSP-1. TSP-1 
also promotes the irreversible aggregation of platelets 
(Tuszynski et al., 1988). TSP-1 appears to be a key 
element in the regulation of wound healing, as seen in a 
murine model, in which inhibition of TSP-l by TSP-1 
antisense oligonucleotides delayed healing and 
epithelization in dermally wounded animals (DiPietro et 
al., 1996). 
TSP-1 has been shown to play a significant role in 
cellular proliferation, a process central to wound healing 
and neoplastic growth. TSP-1 potentiates the mitogenic 
activity of epidermal growth factor for smooth muscle 
cells (Majack et al., 1986). Platelet-derived growth 
factor induces TSP-1 synthesis in smooth muscle cells 
(Majack et al., 1985). TSP-1 stimulates activation of 
smooth muscle cell S6 kinase, a protein kinase involved 
in the transition of cells from the quiescent to the 
proliferative state (Scott-Burden et al., 1988). TSP-1 also 
promotes the proliferation of human fibroblasts in 
culture (Phan et al., 1989). Anti-TSP-l antibodies inhibit 
the growth in culture of smooth muscle cells (Majack et 
al., 1988). TSP-1 is believed to destabilize cell matrix 
contacts, and facilitate mitosis, and migration of cells 
during wound healing and angiogenesis (Murphy-Ulrich 
and Hook, 1989). 
Our laboratory has isolated a unique receptor for 




